TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)
$30.82 -0.14 (-0.4522%)
Analysed TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) News Sources
BofA Raises its Price Target on Teva Pharmaceutical (TEVA) to $42
12-04-2026
yahoo.com
How The Corcept Therapeutics (CORT) Investment Story Is Shifting After Legal And Regulatory Updates
12-04-2026
yahoo.com
AMRX: 3 Growth Drivers Behind Amneal's 2026 Outlook
10-04-2026
yahoo.com
Is AMRX Stock Undervalued? Sales Multiple, Target, Upside
10-04-2026
yahoo.com
Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing
10-04-2026
yahoo.com
Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says
09-04-2026
yahoo.com
Should You Buy, Sell or Hold JNJ Stock Ahead of Q1 Earnings?
09-04-2026
yahoo.com
Israeli Stocks Rise as Investors Weigh Up Fragile Iran Truce
09-04-2026
yahoo.com
Teva Pharmaceutical Industries Limited (TEVA): Billionaire Stan Druckenmiller Trims Position
08-04-2026
yahoo.com
Teva Pharmaceutical: Among the 13 Cheapest Strong Buy Stocks to Buy Right Now
08-04-2026
yahoo.com
What is the current price of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)?
The current price of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) is $30.82.
TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) absolute price change since previous trading day?
The absolute price change of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) since the previous trading day is $-0.14.
TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) percentage price change since previous trading day?
The percentage price change of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) since the previous trading day is -0.4522%.
What is the most recent average sentiment score for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)?
The most recent average sentiment score for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) is 73 out of 100.
What is the most recent average sentiment for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)?
The most recent sentiment for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) is .
SEC-8K** Filing Available For TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.